 Fuller Albright concept postmenopausal osteoporosis years Albright osteoporosis deficiency formation mineralization bone matrix patients osteoporosis age women past menopause young women estrogen stimulates osteoblasts conclusion metabolic balance studies positive calcium balance postmenopausal osteoporosis periodic progesterone endometrial hyperplasia prolonged estrogen therapy long-term therapy vertebral damage height loss postmenopausal osteoporosis Albright time sensitive methods bone density conventional roentgenograms large scale trials estrogen bone density fractures estrogen increases risk endometrial cancer mortality cancers myocardial infarction stroke osteoporosis Trials calcitonin diphosphonates high calcium intake effective estrogen